Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System

References

• Andersen, R. M., P. L. Davidson, and S. E. Baumeister. 2014. Improving access to care: Changing the U.S. health care system: Key issues in health services policy and management. San Francisco, CA: Wiley and Sons.
   Google Scholar
• Andrews, C. M., T. A. D’Aunno, H. A. Pollack, and P. D. Friedmann. 2014. Adoption of evidence-based clinical innovations: The case of buprenorphine use by opioid treatment programs. Medical Care Research and Review: MCRR 71 (1):43–60. doi:10.1177/1077558713503188.
   PubMed Web of Science ®Google Scholar
• Bahorik, A. L., D. D. Satre, A. H. Kline-Simon, C. M. Weisner, and C. I. Campbell. 2016. Alcohol, cannabis, and opioid use disorders, and disease burden in an integrated healthcare system. Journal of Addiction Medicine. doi:10.1097/ADM.0000000000000260.
   Web of Science ®Google Scholar
• Beeuwkes Buntin, M., A. M. Haviland, R. McDevitt, and N. Sood. 2011. Healthcare spending and preventive care in high-deductible and consumer-directed health plans. The American Journal of Managed Care 17 (3):222–30.
   PubMed Web of Science ®Google Scholar
• Benner, J. S., R. J. Glynn, H. Mogun, P. J. Neumann, M. C. Weinstein, and J. Avorn. 2002. Long-term persistence in use of statin therapy in elderly patients. JAMA 288 (4):455–61. doi:10.1001/jama.288.4.455.
   PubMed Web of Science ®Google Scholar
• Boehnke, K. F., E. Litinas, and D. J. Clauw. 2016. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain: Official Journal of the American Pain Society 17 (6):739–44. doi:10.1016/j.jpain.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Caetano, P. A., J. M. Lam, and S. G. Morgan. 2006. Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization. Clinical Therapeutics 28 (9):1411–24, discussion 1410. doi:10.1016/j.clinthera.2006.09.021.
   PubMed Web of Science ®Google Scholar
• California Department of Managed Health Care. 2016. Mental health care. http://www.dmhc.ca.gov/HealthCareinCalifornia/GettheBestCare/MentalHealthCare.aspx#paritylaw.
   Google Scholar
• Centers for Disease Control and Prevention & National Center for Health Statistics. 2015. Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States, 2000–2014. http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf.
   Google Scholar
• Chokshi, D. A., J. E. Chang, and R. M. Wilson. 2016. Health reform and the changing safety net in the United States. The New England Journal of Medicine 375 (18):1790–96. doi:10.1056/NEJMhpr1608578.
   PubMed Web of Science ®Google Scholar
• Covered California. 2016. Coverage levels/metal tiers. http://www.coveredca.com/individuals-and-families/getting-covered/coverage-basics/coverage-levels/ ( accessed January 3, 2017).
   Google Scholar
• Frank, J. W., I. A. Binswanger, S. L. Calcaterra, L. A. Brenner, and C. Levy. 2015. Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey. Drug and Alcohol Dependence 157:150–57. doi:10.1016/j.drugalcdep.2015.10.027.
   PubMed Web of Science ®Google Scholar
• Galbraith, A. A., S. B. Soumerai, D. Ross-Degnan, M. B. Rosenthal, C. Gay, and T. A. Lieu. 2012. Delayed and forgone care for families with chronic conditions in high-deductible health plans. Journal of General Internal Medicine 27 (9):1105–11. doi:10.1007/s11606-011-1970-8.
   PubMed Web of Science ®Google Scholar
• Gordon, N. P. 2006. How does the adult Kaiser Permanente membership in Northern California compare with the larger community? http://www.dor.kaiser.org/external/uploadedFiles/content/research/mhs/_2011_Revised_Site/Documents_Special_Reports/comparison_kaiser_vs_nonKaiser_adults_kpnc%281%29.pdf.
   Google Scholar
• Han, B., S. L. Hedden, R. Lipari, E. A. P. Copello, and L. A. Kroutil. 2015. NSDUH data review: Receipt of services for behavioral health problems: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Hutchinson, E., M. Catlin, C. H. Andrilla, L. M. Baldwin, and R. A. Rosenblatt. 2014. Barriers to primary care physicians prescribing buprenorphine. Annals of Family Medicine 12 (2):128–33. doi:10.1370/afm.1595.
   PubMed Web of Science ®Google Scholar
• Jones, C. M., M. Campopiano, G. Baldwin, and E. McCance-Katz. 2015. National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health 105 (8):e55–63. doi:10.2105/ajph.2015.302664.
   PubMed Web of Science ®Google Scholar
• Kampman, K., and M. Jarvis. 2015. American Society of Addiction Medicine (ASAM) national practice guidelines for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine 9 (5):358–67. doi:10.1097/adm.0000000000000166.
   PubMed Web of Science ®Google Scholar
• Kaur, A. D., A. McQueen, and S. Jan. 2008. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use. Journal of Managed Care Pharmacy: JMCP 14 (2):186–94.
   PubMed Web of Science ®Google Scholar
• Kerr, T., E. Wood, E. Grafstein, T. Ishida, K. Shannon, C. Lai, J. Montaner, and M. W. Tyndall. 2005. High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health 27 (1):62–66. doi:10.1093/pubmed/fdh189.
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., A. J. Abraham, and P. M. Roman. 2011. Adoption and implementation of medications in addiction treatment programs. Journal of Addiction Medicine 5 (1):21–27. doi:10.1097/ADM.0b013e3181d41ddb.
   PubMed Web of Science ®Google Scholar
• Lo-Ciganic, W. H., W. F. Gellad, A. J. Gordon, G. Cochran, M. A. Zemaitis, T. Cathers, D. Kelley, and J. M. Donohue. 2016. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction 111 (5):892–902. doi:10.1111/add.13270.
   PubMed Web of Science ®Google Scholar
• Macias Konstantopoulos, W. L., J. A. Dreifuss, K. A. McDermott, B. A. Parry, M. L. Howell, R. N. Mandler, G. M. Fitzmaurice, M. P. Bogenschutz, and R. D. Weiss. 2014. Identifying patients with problematic drug use in the emergency department: Results of a multisite study. Annals Emergency Medica 64 (5):516–25. doi:10.1016/j.annemergmed.2014.05.012.
   PubMed Web of Science ®Google Scholar
• Mark, T. L., L. M. Wier, K. Malone, M. Penne, and A. J. Cowell. 2015. National estimates of behavioral health conditions and their treatment among adults newly insured under the ACA. Psychiatric Services 66 (4):426–29. doi:10.1176/appi.ps.201400078.
   PubMed Web of Science ®Google Scholar
• Martins, S. S., M. C. Fenton, K. M. Keyes, C. Blanco, H. Zhu, and C. L. Storr. 2012. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine 42 (6):1261–72. doi:10.1017/s0033291711002145.
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., C. Breen, J. Kimber, and M. Davoli. 2008. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2014 (2):CD002207. doi:10.1002/14651858.CD002207.pub4
   Google Scholar
• McLellan, A. T., and A. M. Woodworth. 2014. The Affordable Care Act and treatment for “substance use disorders”: Implications of ending segregated behavioral healthcare. Journal of Substance Abuse Treatment 46 (5):541–45. doi:10.1016/j.jsat.2014.02.001.
   PubMed Web of Science ®Google Scholar
• Mertens, J. R., A. J. Flisher, D. D. Satre, and C. M. Weisner. 2008. The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients. Drug and Alcohol Dependence 98(1–2):45–53. doi:10.1016/j.drugalcdep.2008.04.007.
   PubMed Web of Science ®Google Scholar
• Mertens, J. R., Y. W. Lu, S. Parthasarathy, C. Moore, and C. M. Weisner. 2003. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: Comparison with matched controls. Archives of Internal Medicine 163 (20):2511–17. doi:10.1001/archinte.163.20.2511.
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. 2016. What buprenorphine is and why it’s important. NIDA Archives. https://archives.drugabuse.gov/drugpages/buprenorphine.html.
   Google Scholar
• Nielsen, S., B. Larance, L. Degenhardt, L. Gowing, C. Kehler, and N. Lintzeris. 2016. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews 5 (CD011117). doi:10.1002/14651858.CD011117.pub2.
   Web of Science ®Google Scholar
• Powell, D., and R. L. Pacula. 2015. Do medical marijuana laws reduce addictions and deaths related to pain killers? Santa Monica, CA: RAND.
   Google Scholar
• Ray, G. T., F. Collin, T. Lieu, B. Fireman, C. J. Colby, C. P. Quesenberry, S. K. Van den Eeden, and J. V. Selby. 2000. The cost of health conditions in a health maintenance organization. Medical Care Research and Review 57 (1):92–109. doi:10.1177/107755870005700106.
   PubMed Web of Science ®Google Scholar
• Reichard, J. 2014. Survey shows drop in California's uninsured, but with new cost concerns. The Commonwealth Fund. http://www.commonwealthfund.org/publications/newsletters/washington-health-policy-in-review/2014/aug/aug-4-2014/survey-shows-drop-in-californias-uninsured
   Google Scholar
• Roman, P. M., A. J. Abraham, and H. K. Knudsen. 2011. Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation. Addictive Behaviors 36 (6):584–89. doi:10.1016/j.addbeh.2011.01.032.
   PubMed Web of Science ®Google Scholar
• Satre, D. D., A. Altschuler, S. Parthasarathy, M. J. Silverberg, P. Volberding, and C. I. Campbell. 2016. Implementation and operational research: Affordable Care Act implementation in a California health care system leads to growth in HIV-positive patient enrollment and changes in patient characteristics. Journal of Acquired Immune Deficiency Syndromes 73 (5):e76–e82. doi:10.1097/QAI.0000000000001188.
   PubMed Web of Science ®Google Scholar
• Satre, D. D., J. R. Mertens, P. A. Arean, and C. Weisner. 2004. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction 99 (10):1286–97. doi:10.1111/j.1360-0443.2004.00831.x.
   PubMed Web of Science ®Google Scholar
• Schwarz, R., A. Zelenev, R. D. Bruce, and F. L. Altice. 2012. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. Journal of Substance Abuse Treatment 43 (4):451–57. doi:10.1016/j.jsat.2012.03.008.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. 2013. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. 2016. Buprenorphine. https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine ( accessed January 3, 2017).
   Google Scholar
• Tkacz, J., J. Volpicelli, H. Un, and C. Ruetsch. 2014. Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients. Journal of Substance Abuse Treatment 46 (4):456–62. doi:10.1016/j.jsat.2013.10.014.
   PubMed Web of Science ®Google Scholar
• U.S. Congress. 2010. Patient Protection and Affordable Care Act, 42 U.S.C. § 18001. https://www.gpo.gov/fdsys/pkg/PLAW-111publ148/html/PLAW-111publ148.htm.
   Google Scholar
• Uberoi, N., K. Finegold, and E. Gee. 2016. Health insurance coverage and the affordable care act, 2010–2016. In ASPE Issue Brief, ed. U.S. Department of Health and Human Services. Washington, DC: Department of Health and Human Services.
   Google Scholar
• Volkow, N. D., T. R. Frieden, P. S. Hyde, and S. S. Cha. 2014. Medication-assisted therapies: Tackling the opioid-overdose epidemic. The New England Journal of Medicine 370 (22):2063–66. doi:10.1056/NEJMp1402780.
   PubMed Web of Science ®Google Scholar
• Waters, T. M., C. F. Chang, W. T. Cecil, P. Kasteridis, and D. Mirvis. 2011. Impact of high-deductible health plans on health care utilization and costs. Health Services Research 46 (1 Pt 1):155–72. doi:10.1111/j.1475-6773.2010.01191.x.
   PubMed Web of Science ®Google Scholar
• Watkins, K. E., C. M. Farmer, D. De Vries, and K. A. Hepner. 2015. The Affordable Care Act: An opportunity for improving care for substance use disorders? Psychiatric Services 66 (3):310–12. doi:10.1176/appi.ps.201400159.
   PubMed Web of Science ®Google Scholar
• Weiss, R. D., J. S. Potter, D. A. Fiellin, M. Byrne, H. S. Connery, W. Dickinson, J. Gardin, M. L. Griffin, M. N. Gourevitch, D. L. Haller, A. L. Hasson, Z. Huang, P. Jacobs, A. S. Kosinski, R. Lindblad, E. F. McCance-Katz, S. E. Provost, J. Selzer, E. C. Somoza, S. C. Sonne, and W. Ling. 2011. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 68 (12):1238–46. doi:10.1001/archgenpsychiatry.2011.121.
   PubMed Web of Science ®Google Scholar
• Wells, K. B., E. Keeler, and W. G. Manning, Jr. 1990. Patterns of outpatient mental health care over time: Some implications for estimates of demand and for benefit design. Health Services Research 24 (6):773–89.
   PubMed Web of Science ®Google Scholar
• Wharam, J. F., B. E. Landon, F. Zhang, S. B. Soumerai, and D. Ross-Degnan. 2011. High-deductible insurance: Two-year emergency department and hospital use. American Journal of Managed Care 17 (10):e410–8.
   PubMed Web of Science ®Google Scholar
• Yarborough, B. J., S. P. Stumbo, D. McCarty, J. Mertens, C. Weisner, and C. A. Green. 2016. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis. Drug and Alcohol Dependence 160:112–18. doi:10.1016/j.drugalcdep.2015.12.031.
   PubMed Web of Science ®Google Scholar
• Zeber, J. E., E. Manias, A. F. Williams, D. Hutchins, W. A. Udezi, C. S. Roberts, and A. M. Peterson. 2013. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: A report of the ISPOR medication adherence and persistence special interest group. Value Health 16 (5):891–900. doi:10.1016/j.jval.2013.04.014.
   PubMed Web of Science ®Google Scholar